Latest Breaking News On - Daniel tillett - Page 8 : comparemela.com

Race Oncology reports final data from preclinical melanoma research program

Race Oncology Ltd (ASX:RAC) s Dr Daniel Tillett speaks with Proactive s Andrew Scott after the company reported positive final results from its preclinical.

Daniel tillettAndrew scottRace oncology ltd

Race Oncology Ltd demonstrates synergy between Zantrene and BRAF & MEK inhibitors in treating melanoma

Race Oncology Ltd demonstrates synergy between Zantrene and BRAF & MEK inhibitors in treating melanoma
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Daniel tillettPhillip lynchRace oncology ltd

Race Oncology Ltd s Zantrene improves cancer immunotherapy in preclinical study of treatment-resistant melanoma

Race Oncology Ltd s Zantrene improves cancer immunotherapy in preclinical study of treatment-resistant melanoma
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Daniel tillettPhillip lynchRace oncology ltd

Race Oncology Ltd has novel preclinical data published in prestigious Cancer Research journal, shares up

Race Oncology Ltd (ASX:RAC) has seen two of its peer-reviewed abstracts published in the prestigious scientific journal Cancer Research with shares trading.

Daniel tillettJianjun chenCancer researchRace oncology ltdScientific advisory boardProfessor jianjun chenProfessor chen

Race Oncology Ltd appoints experienced US medicinal chemist to Scientific Advisory Board to guide development programs

Race Oncology Ltd appoints experienced US medicinal chemist to Scientific Advisory Board to guide development programs
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Daniel tillettPhillip lynchAxys pharmaceuticalsRace oncology ltdBristol myers squibbScientific advisory boardConvelo therapeuticsLibra therapeuticsDart neuroscienceBristol myersRace oncology